Drug approvals

This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
KNSS News
November 23, 2020 - 9:59 am
LONDON (AP) — Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are...
Read More
In this Feb. 12, 2019 photo, Meghan Waldron walks down the street in Boston. Waldron is a student at Emerson College with progeria, one of the world's rarest diseases. The first treatment has been approved for progeria, Friday, Nov. 20, 2020. The U.S. Food and Drug Administration on Friday approved Zokinvy which was shown in testing to extend patients’ lives by 2 ½ years on average. (Suzanne Kreiter/The Boston Globe via AP)
November 20, 2020 - 6:06 pm
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives. Kids with the genetic disorder progeria typically die in their early teens, usually from heart disease. But in testing, children...
Read More
What does emergency use of a COVID-19 vaccine mean? AP Illustration/Peter Hamlin
November 20, 2020 - 1:25 pm
What does emergency use of a COVID-19 vaccine mean? It's when regulators allow shots to be given to certain people while studies of safety and effectiveness are ongoing. Before any vaccine is permitted in the U.S., it must be reviewed by the Food and Drug Administration, which requires study in...
Read More
In this March 2, 2020, photo provided by Naomi Worcester, a crew of workers unload gear as they arrive on Kure Atoll in the Northwestern Hawaiian Islands, one of the most remote places on Earth. Cut off from the rest of the planet since February, four environmental field workers are back, re-emerging into a changed society by the coronavirus outbreak. (Naomi Worcester/Hawaii Department of Land and Natural Resources via AP)
November 19, 2020 - 10:17 pm
HONOLULU — Anyone flying to Hawaii will be required to have a negative COVID-19 test result prior to their departure for the state, with the new rule going into effect two days before Thanksgiving, Gov. David Ige announced Thursday. Until now, passengers flying to the islands using a pre-travel...
Read More
President Donald Trump speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. (AP Photo/Evan Vucci)
November 13, 2020 - 7:25 pm
WASHINGTON (AP) — Gliding over significant challenges still to come, President Donald Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. He still did not concede the...
Read More
People wearing face masks to help protect against the spread of the coronavirus feed pigeons on a street in Goyang, South Korea, Wednesday, Nov. 11, 2020. (AP Photo/Ahn Young-joon)
November 12, 2020 - 10:31 pm
WELLINGTON, New Zealand — New Zealand’s government could soon make wearing masks mandatory on public transit in Auckland and on planes nationwide as it continues to investigate a new community case of the coronavirus. Virus Response Minister Chris Hipkins says there are no plans at this point to...
Read More
This photo provided by Eli Lilly shows the drug Bamlanivimab. On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)
November 09, 2020 - 9:50 pm
WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans. The Food and Drug Administration on Monday cleared the experimental drug...
Read More
Pedestrians walk past Pfizer world headquarters in New York on Monday Nov. 9, 2020. Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, but it doesn't mean a vaccine is imminent. (AP Photo/Bebeto Matthews)
November 09, 2020 - 7:48 pm
Pfizer's surprising news that its COVID-19 vaccine might offer more protection than anticipated — an announcement right after a fraught U.S. presidential election campaign — is raising questions about exactly how the different shots will make it to market. Pfizer Inc. and the maker of the other...
Read More
In this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer’s disease research in a laboratory at the drugmaker’s headquarters in Cambridge, Mass. On Friday, Nov. 6, 2020, a panel of outside experts will meet to advise the Food and Drug Administration on the drug, called aducanumab from Biogen Inc. and Japan’s Eisai Co. The drug does not cure or reverse Alzheimer’s; the claim is that it modestly slows the rate of decline. (David A. White/Biogen via AP)
November 06, 2020 - 4:50 pm
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease. The panel of outside experts for the Food and Drug Administration agreed that a...
Read More
FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)
November 05, 2020 - 3:51 pm
LONDON (AP) — AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses starting in January, Chief Executive Pascal Soriot said Thursday. The Anglo-Swedish drugmaker is working with the...
Read More

Pages